Ahead of the federal Food and Drug Administration's scheduled meeting Oct. 26 to consider authorizing Pfizer's COVID-19 vaccine for 5-to 11-year-olds, Austin Public Health is anticipating increased demand for the Pfizer shot.
APH interim Director Adrienne Sturrup told local officials Oct. 12 that an effort is underway to prepare for the added 114,519 Travis County residents that will become eligible for the vaccine if the FDA authorizes it for use in 5- to 11-year-olds later this month.
"We're looking at making sure we have an adequate supply in anticipation of the increased demand for Pfizer," Sturrup said at a joint session of Austin City Council and the Travis County Commissioners Court. "Because [Pfizer will be] the only option for kiddos, we want to make sure we have enough vaccine on hand."
Since late 2020, when COVID-19 vaccines became available, Sturrup said APH has predominantly provided residents with Moderna's vaccine, which is not slated to be authorized for children yet. Pfizer's vaccine—now officially called Comirnaty since securing full FDA approval in August—requires deep-freezing technology to maintain its shelf life, making it difficult for some providers to manage compared to Moderna's and Johnson & Johnson's shots.












